
E
Tier
Pegylated, longer-acting MGF.
Muscle & Performance
Modified protein, splice variant of IGF-1
WADA Status:
Prohibited by category (S2.3, MGFs)
Human Trial Scoreboard
Completed human RCTs
None completed
Largest Human Study
No human studies
Longest exposure
None studied
Most Recent Trial
No completed trial
Description
PEG-MGF is mechano growth factor with polyethylene glycol chains attached, a standard pharmaceutical technique for slowing the breakdown of a molecule and extending how long it lasts in the body. The modification is legitimate chemistry. What it modifies is a compound that has never been tested in a human trial, so the result is a longer-acting version of something whose effects in people are unknown. There is no development programme and no published human study. It is prohibited in tested sport under the category covering mechano growth factors, and the pegylation does not change any of that.
What Are The Claims
Claims made for this compound: Sustained muscle-repair signaling
Evidence
A pegylated modification of an already-unstudied compound. No human data.
Evidence Strength
Animal/preclinical only
Caveats
Safety
Alternative Measures
Legal Status
US
Not approved
UK
Not approved
EU
Not approved
AU
Not approved
WADA
Prohibited by category (S2.3, MGFs)
Not approved. Research chemical. WADA-prohibited.
Citations
No completed peer-reviewed human clinical trial exists for this compound. Where a citation is absent below, that absence is the finding.